Vaccine Stocks Jump on U.S. Bird-Flu Death
Shares of vaccine makers including Moderna, Novavax and CureVac rose Tuesday after U.S. health officials confirmed the first American death caused by the H5N1 bird flu. Moderna and Novavax shares rose more than 10%,
Moderna and other vaccine maker shares jump after first US bird flu death
Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its first death from the virus.
Moderna Stock Jumps Amid Bird Flu Vaccine Hope After First U.S. Death
The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through North America.
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
Moderna stock was on track to see a weekly gain of 10% as of Wednesday following the first reported bird flu death in the US.
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death
The first bird-flu fatality in the United States sparks investor interest in several vaccine makers that are developing experimental H5N1 vaccines.
US to Build New Stockpile of Bird Flu Vaccine for Poultry
The U.S. will rebuild its stockpile of bird flu vaccines for poultry matched to the current strain of the virus circulating among commercial flocks and wild birds, the Department of Agriculture said on Wednesday.
Why CureVac (CVAC) Shares Are Volatile
CureVac shares have been volatile over the past week, gaining some 25%. The stock has seen increased trading volume following ...
CureVac: Latest GBM Data Bodes Well For Next Program Check Point
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
bovnews1d
Why Did Leerink Partners Give CureVac BV (CVAC) Stock Market Perform Rating?
Leerink Partners has recently reduced CureVac BV (CVAC) stock to Market Perform rating, as announced on April 25, 2024, according to Finviz. Earlier, on June 8, 2023, SVB Securities had initiated the ...
Why CureVac (CVAC) Stock Is Moving
Shares of CureVac fell by 12.3% Wednesday afternoon. The pullback may stem from profit-taking after Tuesday's strong gains ...
Hosted on MSN4d
Moderna, Novavax Stocks Climb Pre-Market On Growing Bird Flu Concerns: Retail Engagement Soars
Shares of Moderna, Inc. and Novavax, Inc. jumped premarket Tuesday, rising as much as about 6% and nearly 8%, respectively, ...
bovnews4d
CureVac BV (CVAC) Stock Rated Market Perform by Leerink Partners
CureVac BV (CVAC) stock saw a modest uptick, ending the day at $4.44 which represents a slight increase of $0.82 or 22.65% from the prior close of $3.62. The stock opened at $4.14 and touched a low of ...
pharmaphorum1y
CureVac claims advantage in BioNTech patent dispute
A court in Germany has suspended a trial discussing litigation brought against BioNTech and Pfizer by CureVac alleging patent infringement in connection with their mRNA-based vaccines against ...